Personalis vs Exagen
PSNL and XGN side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PSNL and XGN compare
Personalis is the larger company, worth 17 times as much as Exagen ($1.7B against $100M).
Personalis grew revenue faster over the last twelve months (16.9% versus 13.7% for Exagen).
Exagen keeps more of each dollar of sales as profit, with a net margin of −25.1% compared with −148% at Personalis.
Personalis scores higher on the StockData Score (5 against 4 for Exagen), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PSNL | XGN |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $100M |
| Share price | $15.71 | $4.13 |
| Change, 1 year | 96.1% | −56.9% |
| Change, 5 years | 5.1% | −65.9% |
| Beta (5Y) | 1.87 | 1.18 |
| Employees | 260 | 220 |
| StockData Score | ||
| Total score | 5 (better) | 4 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 0 | 1 (better) |
| Health score | 5 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 20.8× | 1.4× (better) |
| P/B | 7.9× | 7.3× (better) |
| FCF yield | −6.4% (better) | −13.0% |
| Fair value | $3.28 | $3.60 |
| Margin of safety | −379% | −14.7% (better) |
| Growth | ||
| Revenue growth (TTM) | 16.9% (better) | 13.7% |
| Revenue growth, 5Y average | −2.4% | 9.7% (better) |
| Profitability | ||
| Gross margin | 16.7% | 58.7% (better) |
| Operating margin | −157% | −20.1% (better) |
| Net margin | −148% | −25.1% (better) |
| FCF margin | −133% | −18.0% (better) |
| Return on equity | −62.1% (better) | −114% |
| Return on invested capital | −465% | −167% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 1.66 (better) |
| Interest coverage | −684.0× | −2.9× (better) |
| Current ratio | 4.53 (better) | 3.46 |
| Altman Z-score | 8.83 (better) | −5.71 |
| Piotroski F-score | 4 | 4 |
| Dividends and buybacks | ||
| Buyback yield | −8.0% | – |
| Shareholder yield | −8.0% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 79.6% | 34.1% |
| Held by insiders | 15.0% | 29.2% |
| Insider net buying, 12 months | −$6.9M | −$22.9K (better) |
| Short interest, % of float | 7.4% | 4.2% |
Go deeper
- PSNL stock overview
- PSNL income statement
- PSNL valuation and score
- XGN stock overview
- XGN income statement
- XGN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.